Home › Calculator › ANPCF Dividend Calculator 2026
ANPCF Dividend DRIP Calculator 2026
10050.25% YieldHealthcareCellbxhealth PLC · OTC
Price: $0.02 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ANPCF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ANPCF snowball 📈
$10,000 in ANPCF → $190363905853969727488.00M in 10 years · $15,813,482,461,954,866,000,000,000.00/month
About Cellbxhealth PLC (ANPCF) — Dividend Analysis 2026
CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.
Compare ANPCF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ANPCF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ANPCF position with:
🌍 ANPCF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ANPCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 10050.25% | 10047.45% | $1,005,025 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 8542.71% | 8539.91% | $854,271 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 8040.20% | 8037.40% | $804,020 / yr |
| 🇬🇧 UK ISA | 0% | 10050.25% | 10047.45% | $1,005,025 / yr |
| 🇬🇧 UK Taxable | 8.75% | 9170.85% | 9168.05% | $917,085 / yr |
| 🇨🇦 TFSA | 0% | 10050.25% | 10047.45% | $1,005,025 / yr |
| 🇨🇦 CA Taxable | 25% | 7537.69% | 7534.89% | $753,769 / yr |
| 🇦🇺 Super (pension) | 15% | 8542.71% | 8539.91% | $854,271 / yr |
| 🇦🇺 AU Taxable | 30% | 7035.17% | 7032.37% | $703,518 / yr |
| 🇩🇪 DE Taxable | 26.375% | 7399.50% | 7396.70% | $739,950 / yr |
| 🇫🇷 FR Taxable | 30% | 7035.17% | 7032.37% | $703,518 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ANPCF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ANPCF Dividend Payment Schedule
ANPCF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ANPCF vs Healthcare Benchmarks
How ANPCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ANPCF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ANPCF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ANPCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cellbxhealth PLC (ANPCF) is currently trading at $0.02, 99% below its 52-week high. The current dividend yield is 10050.25% based on an annual payout of $2.00 per share.
ANPCF (Cellbxhealth PLC) — 10050.25% Dividend Yield Analysis
Cellbxhealth PLC (ANPCF) is a healthcare stock currently trading at $0.02 with a dividend yield of 10050.25%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (10050.25%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.